Safety and Efficacy Study of Daptomycin Compared to Active Comparator in Pediatric Participants With Acute Hematogenous Osteomyelitis (AHO) (MK-3009-006)
Clinical trial NCT01922011 · COMPLETED
Trial details
- NCT number
- NCT01922011
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-13
- Primary completion
- 2016-06-14
- Enrollment
- 149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.